The choice of therapy for end-stage renal disease (ESRD) in the 1990s is influenced by several factors that should be collectively considered for each patient. With the increased safety and success of kidney transplantation, maintenance chronic dialysis has largely become limited to transplant exclusions or transplant failures. Conversely, transplantation is now considered the preferred therapy for those patients who are able to undergo surgery. The progressive increase in patients awaiting kidney transplantation mandates careful patient selection for this limited resource in keeping with biologic and ethical principles.
展开▼